Publicação
AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma
| Resumo: | This master's thesis delivers an in-depth analysis of AstraZeneca's financial performance, business model, and competitive positioning within the dynamic pharmaceutical industry. By examining the company's strategy, competitive advantages, and growth opportunities, the study highlights potential future successes and challenges. This equity research report provides investors with a comprehensive evaluation of AstraZeneca, offering valuable insights into the fair value of its stock to support well-informed investment decisions. |
|---|---|
| Autores principais: | Iakimov, Timur |
| Assunto: | Finance Valuation AstraZeneca Pharmaceuticals |
| Ano: | 2025 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| _version_ | 1868984233834315776 |
|---|---|
| author | Iakimov, Timur |
| author_facet | Iakimov, Timur |
| author_role | author |
| contributor_name_str_mv | André, Rosário RUN |
| country_str | PT |
| creators_json_txt | [{\"Person.name\":\"Iakimov, Timur\"}] |
| datacite.contributors.contributor.contributorName.fl_str_mv | André, Rosário RUN |
| datacite.creators.creator.creatorName.fl_str_mv | Iakimov, Timur |
| datacite.date.Accepted.fl_str_mv | 2025-01-24T00:00:00Z |
| datacite.date.available.fl_str_mv | 2026-03-04T14:18:01Z |
| datacite.date.embargoed.fl_str_mv | 2026-03-04T14:18:01Z |
| datacite.rights.fl_str_mv | http://purl.org/coar/access_right/c_abf2 |
| datacite.subjects.subject.fl_str_mv | Finance Valuation AstraZeneca Pharmaceuticals |
| datacite.titles.title.fl_str_mv | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| dc.contributor.none.fl_str_mv | André, Rosário RUN |
| dc.creator.none.fl_str_mv | Iakimov, Timur |
| dc.date.Accepted.fl_str_mv | 2025-01-24T00:00:00Z |
| dc.date.available.fl_str_mv | 2026-03-04T14:18:01Z |
| dc.date.embargoed.fl_str_mv | 2026-03-04T14:18:01Z |
| dc.format.none.fl_str_mv | application/pdf |
| dc.identifier.none.fl_str_mv | http://hdl.handle.net/10362/200954 |
| dc.language.none.fl_str_mv | eng |
| dc.rights.cclincense.fl_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.none.fl_str_mv | http://purl.org/coar/access_right/c_abf2 |
| dc.subject.none.fl_str_mv | Finance Valuation AstraZeneca Pharmaceuticals |
| dc.title.fl_str_mv | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| dc.type.none.fl_str_mv | http://purl.org/coar/resource_type/c_bdcc |
| description | This master's thesis delivers an in-depth analysis of AstraZeneca's financial performance, business model, and competitive positioning within the dynamic pharmaceutical industry. By examining the company's strategy, competitive advantages, and growth opportunities, the study highlights potential future successes and challenges. This equity research report provides investors with a comprehensive evaluation of AstraZeneca, offering valuable insights into the fair value of its stock to support well-informed investment decisions. |
| dirty | 0 |
| eu_rights_str_mv | openAccess |
| format | masterThesis |
| fulltext.url.fl_str_mv | https://run.unl.pt/bitstreams/71d42019-c107-4d26-b165-959f56c4e668/download |
| id | run_faba8a0fa9b7111e129ae5f5e79f9b2d |
| identifier.url.fl_str_mv | http://hdl.handle.net/10362/200954 |
| inst_facet_str | urn:organizationAcronym:unl{{{_:::_}}}Universidade Nova de Lisboa |
| instacron_str | unl |
| institution | Universidade Nova de Lisboa |
| instname_str | Universidade Nova de Lisboa |
| language | eng |
| network_acronym_str | run |
| network_name_str | Repositório Institucional da UNL |
| oai_identifier_str | oai:run.unl.pt:10362/200954 |
| organization_str_mv | urn:organizationAcronym:unl |
| person_str_mv | Iakimov, Timur |
| publishDate | 2025 |
| repo_facet_str | urn:repositoryAcronym:run{{{_:::_}}}Repositório Institucional da UNL |
| reponame_str | Repositório Institucional da UNL |
| repository_id_str | urn:repositoryAcronym:run |
| service_str_mv | urn:repositoryAcronym:run |
| spelling | engengThis master's thesis delivers an in-depth analysis of AstraZeneca's financial performance, business model, and competitive positioning within the dynamic pharmaceutical industry. By examining the company's strategy, competitive advantages, and growth opportunities, the study highlights potential future successes and challenges. This equity research report provides investors with a comprehensive evaluation of AstraZeneca, offering valuable insights into the fair value of its stock to support well-informed investment decisions.application/pdfengAstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharmaIakimov, TimurAndré, RosárioHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptURNurn:tid:2041307272026-03-04T14:18:01Z2025-01-242024-12-172025-01-24T00:00:00ZHandlehttp://hdl.handle.net/10362/200954http://purl.org/coar/access_right/c_abf2open accessFinanceValuationAstraZenecaPharmaceuticals836112 bytesliteraturehttp://purl.org/coar/resource_type/c_bdccmaster thesis2025-01-24http://creativecommons.org/licenses/by/4.0/http://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/71d42019-c107-4d26-b165-959f56c4e668/download |
| spellingShingle | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma Iakimov, Timur Finance Valuation AstraZeneca Pharmaceuticals |
| status | SINGLETON |
| subject.fl_str_mv | Finance Valuation AstraZeneca Pharmaceuticals |
| title | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| title_full | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| title_fullStr | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| title_full_unstemmed | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| title_short | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| title_sort | AstraZeneca equity research - driving growth through innovation, strategic portfolios, and sustainability in pharma |
| topic | Finance Valuation AstraZeneca Pharmaceuticals |
| topic_facet | Finance Valuation AstraZeneca Pharmaceuticals |
| url | http://hdl.handle.net/10362/200954 |
| visible | 1 |